Main Article Content
This article estimates the role of Gln27Glu polymorphism of β2-adrenergic receptors gene in forming violations of carbohydrate and lipid metabolism in obese patients with ischemic heart disease.
A comprehensive survey of 222 patients with ischemic heart disease and obesity was conducted. The study determined the carbohydrate, lipid metabolism and gene allelic polymorphism of Gln27Glu of β2-adrenergic receptors gene.
Comorbidity of ischemic heart disease and obesity is characterized by hyperinsulinemia and insulin resistance on the background of normoglycemia that is associated with the G/G genotype polymorphism of Gln27Glu of β2-adrenergic receptors gene. G/G genotype polymorphism gene of Gln27Glu β2-adrenergic receptors in patients with ischemic heart disease is associated with increased body mass index and triglyceride levels.
In our study, we provided evidence of the influence of genotype G/G of Gln27Glu polymorphism of β2-adrenergic receptors gene in patients with ischemic heart disease and obesity on carbohydrate and lipid metabolism. Homozygotes (G/G) had elevated insulin levels, insulin resistance, body mass index and triglycerides.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. / P. Poirier, TD. Giles, GA. Bray et al. Circulation. 2006;113: 898-918.
Beta-1 and beta-2 adrenoreceptor polymorphisms: functional impotance, impact on cardiovascular disease and drug responses. OE. Brodde. Pharmacol Ther. 2008; 117:1-29.
Beta-2 adrenoceptor polymorphism determines vascular reactivity in humans / JR. Cockcroft, AG. Gazis, DJ. Cross et al. Hypertension. 2000;36:371-75.
Beta2-adrenergic receptor genotypes and haplotypes in different ethnic groups. / TJ. Maxwell, MM. Ameyaw, S Pritchard. Int J Mol Med. 2005;16:573-80.
Role of beta(2)-adrenergic receptor polymorphisms on body weight and body composition response to energy restriction in obese women: preliminary results. Ruiz JR, Larrarte E, Margareto J, Ares R, Labayen I. Obesity (Silver Spring). 2011;19:212-15.
Association of ADRB2 polymorphism with triglyceride levels in Tongans. / Naka IOJ, Kimura R, Inaoka T, Matsumura Y. Lipids in Health and Disease. 2013;12:1-5.
Association of polymorphism in the β2-adrenergic receptor gene with obesity, hypertriglyceridemia, and diabetes mellitus. Ishiyama-Shigemoto S, Yamada K, Yuan X, Nonaka K. Diabetologia. 1999; 42: 98-101.
Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. V. Large, L Hellstrom, S Reynisdottir et al. J Clin Invest. 1997; 100: 3005-12.
The different effects of Gln27Glu β2-adrenoceptor gene polymorphism on obesity in males and in females. Hellstrom L, Large V, Reynisdottir S, Wahrenberg H, Arner P. J Intern Med. 1999; 245: 253-9.
Gln27Glu variant of Beta 2-adrenoreceptor gene affects male type fat accumulation in women. Kunnas T, Lachitioo R, Kortelainen MJ, Kalela A, Nikkari ST. Lipids in Health and Disease. 2009;43:1-4.
β2-adrenoceptor polymorphisms relate to obesity through blunted leptin mediated sympathetic activation. K Masuo, T Katsuya, H Kawaguchi et al. Am J Hypertens. 2006; 19: 1084-91.
The Gln27Glu β2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Y Mori, H Kim-Motoyama, Y Ito et al. Biochem Biophys Res Commun. 1999; 258: 138-40.
Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene are not associated with obesity in Japanese men. T Hayakawa, Y Nagai, T Kahara et al. Metabolism. 2000; 49: 1215-18.
Lack of association between a human beta2-adrenoceptor gene polymorphism (gln27glu) and morbid obesity. Kortner B, Wolf AM, Wendt D, Beisiegel U, Evans D. Int J Obes Relat Metab Disord. 2000; 23: 1099-100.
The Gln27Glu polymorphismin the beta2-adrenergic receptor gene is not associated with morbid obesity in Austrian women. H Oberkofler, H Esterbauer, E Hell. Int J Obes Relat Metab Disord. 2000; 24:388-90.